Skip to main content
. 2020 Aug 4;9(8):2514. doi: 10.3390/jcm9082514

Table 2.

Nodules diagnoses and numbers.

Malignant 46 (71%)
Adenocarcinoma 23 (35%)
Squamous cell carcinoma 18 (28%)
Large cell neuroendocrine carcinoma 3 (4%)
Squamous cell (95%) and neuroendocrine carcinoma 1 (2%)
Small cell carcinoma 1 (2%)
Benign 19 (29%)
Inflammatory infiltrations 9 (14%)
Sarcoidosis 5 (8%)
Fibroma 2 (4%)
Hamartoma 1 (1%)
Hematoma 1 (1%)
Tuberculoma 1 (1%)